Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua

International Journal of Antimicrobial Agents

Volumn 23, Issue 5, 2004, Pages 506-509

  Matute, A J ^a   Hak, E ^b   Schurink, C A M ^b   McArthur, A ^b   Alonso, E ^a   Paniagua, M ^a   Van Asbeck, E ^b   Roskott, A M ^b   Froeling, F ^b   Rozenberg Arska, M ^b   Hoepelman, I M ^b  

^a National Autonomous University of Nicaragua   (Nicaragua)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibiotics; Epidemiology; Resistance; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALOTIN; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; NITROFURANTOIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CLINICAL FEATURE; CYSTOCELE; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NICARAGUA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PYURIA; RISK ASSESSMENT; RISK FACTOR; URINARY TRACT INFECTION;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIA; CEPHALOTHIN; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA; MALE; MICROBIAL SENSITIVITY TESTS; NICARAGUA; PYURIA; QUINOLONES; RISK FACTORS; SULFAMETHIZOLE; TRIMETHOPRIM; URINARY BLADDER DISEASES; URINARY INCONTINENCE; URINARY TRACT INFECTIONS; URINE;

EID: 2342486037     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.10.003     Document Type: Article

References (22)

1. Ferry S., Burman L.G., Holm S.E. Clinical and bacteriological affects of therapy of urinary tract infection in primary health care: relation to in vitro testing. Scand. J. Infect. Dis. 20:1988;535-544
2. Olafsson M., Kristinsson K.G., Sigurdsson J.A. Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs. Scand. J. Prim. Health Care. 18:2000;35-38
3. Musa-Aisien A.S., Ibadin O.M., Ukoh G. Prevalence and antimicrobial sensitivity pattern in urinary tract infection in febrile under- 5s at a children's emergency unit in Nigeria. Ann. Trop. Pediatr. 23:2003;39-45
4. Cunninghan F.G., Lucas M.J. Urinary tract infections complicating pregnancy. Bailers Clin. Obstet. Gynaecol. 8:1994;353-733
5. Ruben F.L., Dearwater S.T., Norden C.W. Clinical infections in the non institutionalized geriatric age group: Methods utilized and incidence of infections. And. J. Epidemiol. 141:1995;145-157
6. Geerlings S.E., Meiland R., Hoepelman I.M. Pathogenesis of bacteriuria in women with diabetes mellitus. Int. J. Antimicrob. Agents. 19:2002;539-543
7. Talan D.A., Stamm W.E., Hooton T.M., et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women. JAMA. 283:2000;1583-1590
8. Raz R., Chazan B., Kennes Y., et al. Empiric use of trimethoprim- sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin. Infect. Dis. 34:2002;1165-1169
9. Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin. Infect. Dis. 15(suppl 1):1992;S216-S227
10. Wood GL, Washington JA. Antimicrobial susceptibility test dilution and desk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 6th ed. Washington: American Society for Microbiology; 1995. p. 1327-41.
11. Nava L, Fiorentini, Stena MM. Comparative study of the microbiological components in urinary tract infections. J It Chemother 1989;36:69-87.
12. Finkelsteim R., Kassis E., Reinhetz G., Gorenstein S. Community acquired urinary tract infections in adults. J. Hosp. Infect. 38:1998;193-202
13. Williams D.N., Sannes M.R., Eckhoff A., Peterson P.K. Antimicrobial resistance in Escherichia coli causing urinary tract infection in Costa Rica: a clinical dilemma. Int. J. Antimicrob. Agents. 21:2003;79-81
14. Gupta K., Sahm D.F., Mayfield D., Stamm W.E. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a national analysis. Clin. Infect. Dis. 33:2001;89-94
15. Gales A.C., Sader H.S., Jones R.N. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn. Microbiol. Infect. Dis. 44:2002;289-299
16. Forrell D.J., Morrissey I., Rubeis D., Robbins M., Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J. Infect. 46:2003;94-100
17. Turnidge J., Bell J., Biedenbach D.J., Jones R.N. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY antimicrobial surveillance program, 1998-1999. Int. J. Antimicrob. Agents. 20:2002;10-17
18. Gales A.C., Jones R.N., Gordon K.A., et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program. J. Antimicrob. Chemother. 45:2000;295-303
19. Felmingham D., Arakawa S. Resistance among urinary pathogens: experience outside the USA. Clin. Drug Invest. 21:2001;7-11
20. Guzman B.M., Casellas J.M., Sader H.S. Bacterial resistance to antimicrobial agents in Latin America: the giant is awakening. Infect. Dis. Clin. North Am. 14(1):2000;67-81
21. Warren J.W., Abrutyn E., Hebel J.R., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29:1999;745-758
22. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Supplemental M100-S11. Wayne, PA: National Committee for Clinical Laboratory Standards; 2001.